ORIGINAL PAPER
You have free access to this content
Can Access Limits on Sales Representatives to Physicians Affect Clinical Prescription Decisions? A Study of Recent Events With Diabetes and Lipid Drugs
Article first published online: 21 MAY 2012
DOI: 10.1111/j.1751-7176.2012.00651.x
© 2012 Wiley Periodicals, Inc.
Additional Information
How to Cite
Chressanthis, G. A., Khedkar, P., Jain, N., Poddar, P. and Seiders, M. G. (2012), Can Access Limits on Sales Representatives to Physicians Affect Clinical Prescription Decisions? A Study of Recent Events With Diabetes and Lipid Drugs. The Journal of Clinical Hypertension, 14: 435–446. doi: 10.1111/j.1751-7176.2012.00651.x
Publication History
- Issue published online: 2 JUL 2012
- Article first published online: 21 MAY 2012
- Manuscript received: October 18, 2011; revised: March 9, 2012; accepted: March 16, 2012
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- You have free access to this content1, , Should Physicians Rely on Pharmaceutical Detailing for their Education?, The Journal of Clinical Hypertension, 2013, 15, 3Direct Link:
- You have free access to this content2, , , , , Suppressing Commercial Speech is Not in the Best Interests of Physicians and Patients, The Journal of Clinical Hypertension, 2013, 15, 3Direct Link:

1751-7176/asset/olbannerleft.gif?v=1&s=e1329e97d266c876232b9dd119e3a8eb68b7184c)
1751-7176/asset/olbannerright.gif?v=1&s=41f410e8e629a1248a3cd67bdebc1514226c9ea8)
